Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$344K Sell
14,302
-2,249
-14% -$58.8K 0.07% 123
2026
Q1
$465K Buy
16,551
+1,602
+11% +$42.7K 0.1% 107
2025
Q4
$372K Sell
14,949
-647
-4% -$16.3K 0.08% 120
2025
Q3
$397K Sell
15,596
-1,370
-8% -$33.8K 0.09% 117
2025
Q2
$411K Sell
16,966
-1,239
-7% -$28.9K 0.09% 115
2025
Q1
$461K Sell
18,205
-2,136
-11% -$55.9K 0.11% 104
2024
Q4
$540K Sell
20,341
-1,321
-6% -$35.8K 0.13% 98
2024
Q3
$627K Buy
21,662
+191
+0.9% +$5.57K 0.15% 89
2024
Q2
$601K Sell
21,471
-4,915
-19% -$135K 0.15% 87
2024
Q1
$732K Sell
26,386
-3,776
-13% -$105K 0.18% 86
2023
Q4
$868K Sell
30,162
-195
-0.6% -$5.89K 0.23% 74
2023
Q3
$1.01M Sell
30,357
-585
-2% -$20.7K 0.29% 66
2023
Q2
$1.13M Sell
30,942
-1,244
-4% -$48.4K 0.31% 64
2023
Q1
$1.31M Sell
32,186
-3,022
-9% -$131K 0.39% 57
2022
Q4
$1.8M Sell
35,208
-14,242
-29% -$683K 0.55% 44
2022
Q3
$2.16M Sell
49,450
-1,447
-3% -$70.3K 0.66% 42
2022
Q2
$2.67M Buy
50,897
+3,473
+7% +$177K 0.78% 38
2022
Q1
$2.46M Sell
47,424
-36,863
-44% -$1.91M 0.58% 45
2021
Q4
$4.98M Sell
84,287
-4,732
-5% -$234K 1.1% 24
2021
Q3
$3.83M Sell
89,019
-1,675
-2% -$74.2K 0.93% 28
2021
Q2
$3.55M Sell
90,694
-9,679
-10% -$376K 0.86% 33
2021
Q1
$3.64M Sell
100,373
-2,184
-2% -$77.5K 0.91% 29
2020
Q4
$3.77M Sell
102,557
-4,937
-5% -$181K 0.94% 25
2020
Q3
$3.74M Buy
+107,494
New +$3.77M 0.99% 26

Other funds holding PFE

Berkshire Bank's PFE Position: Q2 2026 in Review

Berkshire Bank reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $58.8K and leaving 14,302 shares worth $344K. The position accounts for 0.07% of the portfolio, ranked #123.

Berkshire Bank first reported a position in PFE in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.98M in Q4 2021. 1,377 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Berkshire Bank held 14,302 shares of Pfizer worth $344K as of Q2 2026.
  • Berkshire Bank sold 2,249 Pfizer shares in Q2 2026, an estimated $58.8K.
  • Pfizer made up 0.07% of Berkshire Bank's portfolio in Q2 2026, its #123 holding.
  • Berkshire Bank first reported a position in Pfizer in Q3 2020 and has held it in 24 quarters since.
  • Berkshire Bank's Pfizer position peaked at $4.98M in Q4 2021.
  • 1,377 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Berkshire Bank's 13F filing for Q2 2026, filed 8 Jul 2026.